The Mitochondrial Deubiquitinase USP30 Regulates AKT/mTOR Signaling.

Zhang, Ruohan; Ozgen, Serra; Luo, Hongke; Krigman, Judith; Zhao, Yutong; Xin, Gang; Sun, Nuo

Zhang, Ruohan; Ozgen, Serra; Luo, Hongke; Krigman, Judith; Zhao, Yutong; Xin, Gang; Sun, Nuo.

Afiliación

Zhang R; Department of Physiology and Cell Biology, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
Ozgen S; Division of Pharmaceutics and Pharmacology, The Ohio State University College of Pharmacy, Columbus, OH, United States.
Luo H; Department of Physiology and Cell Biology, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
Krigman J; Department of Physiology and Cell Biology, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
Zhao Y; Department of Physiology and Cell Biology, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
Xin G; Department of Physiology and Cell Biology, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
Sun N; Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, United States.

Front Pharmacol ; 13: 816551, 2022.

Article en En | MEDLINE | ID: mdl-35250566

Palabras clave

USP30; akt; cancer; leukemia; mTOR; mitophagy; parkin

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google